Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization: A Review from a Malaysian Perspective
Open Access
- 31 October 2017
- journal article
- review article
- Published by Wiley in International Journal of Nephrology
- Vol. 2017, 1-7
Abstract
End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients’ access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.Keywords
This publication has 50 references indexed in Scilit:
- Nephrologists’ perspectives on dialysis treatment: results of an international surveyBMC Nephrology, 2014
- The Gap between Estimated Incidence of End-Stage Renal Disease and Use of TherapyPLOS ONE, 2013
- Financing Universal Coverage in Malaysia: a case studyBMC Public Health, 2012
- Health-related quality of life and existential concerns among patients with end-stage renal diseaseIndian Journal of Palliative Care, 2012
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesKidney International, 2011
- Cost-effectiveness analysis of renal replacement therapy in AustriaNephrology Dialysis Transplantation, 2011
- In Peritoneal Dialysis, Is There Sufficient Evidence to Make “PD First” Therapy?International Journal of Nephrology, 2011
- How can we achieve global equity in provision of renal replacement therapy?Bulletin of the World Health Organization, 2008
- Reimbursement and economic factors influencing dialysis modality choice around the worldNephrology Dialysis Transplantation, 2008
- Non-medical factors influencing peritoneal dialysis utilization: the Swiss experienceNephrology Dialysis Transplantation, 2004